Stock-Based Compensation (Stock-Settled Stock Appreciation Rights Activity) (Details) - Stock Settled Stock Appreciation Rights SARS [Member] - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Number of Rights
Number of Rights, Outstanding at beginning of year (in rights)	454
Number of Rights, Exercised (in rights)	(44)
Number of Rights, Granted (in rights)	0	124	180
Number of Rights, Forfeited (in rights)	(17)
Number of Rights, Outstanding at end of year (in rights)	393	454
Number of Rights, Exercisable and vested at end of year (in rights)	265
Number of Rights, Vested and expected to vest at end of year (in rights)	393
Weighted Average Exercise Price
Weighted Average Exercise Price, Outstanding at beginning of year (in dollars per share)	$ 156.49
Weighted Average Exercise Price, Exercised (in dollars per share)	138.20
Weighted Average Exercise Price, Granted (in dollars per share)	0
Weighted Average Exercise Price, Forfeited (in dollars per share)	167.03
Weighted Average Exercise Price, Outstanding at end of year (in dollars per share)	158.12	$ 156.49
Weighted Average Exercise Price, Exercisable and vested at end of year (in dollars per share)	153.36
Weighted Average Exercise Price, Vested and expected to vest at end of year (in dollars per share)	$ 158.13
Weighted Average Remaining Contractual Life in Years
Weighted Average Remaining Contractual Life in Years, Outstanding at end of year	2 years 6 months 10 days
Weighted Average Remaining Contractual Life in Years, Exercisable and vested at end of year	2 years 2 months 8 days
Weighted Average Remaining Contractual Life in Years, Vested and expected to vest at end of year	2 years 6 months 10 days
Aggregate Intrinsic Value
Aggregate Intrinsic Value, Outstanding at end of year	$ 269
Aggregate Intrinsic Value, Exercisable and vested at end of year	269
Aggregate Intrinsic Value, Vested and expected to vest at end of year	$ 269